Associations between Magnetic Resonance Imaging Findings and Clincopathologic Factors in Triple-Negative Breast Cancer

    Research output: Contribution to journalArticlepeer-review

    4 Scopus citations

    Abstract

    Objective The aim of the study was to evaluate the magnetic resonance imaging findings associated with clinicopathologic factors in patients with triple-negative breast cancer. Methods One hundred one patients with surgically confirmed triple-negative breast cancer who underwent preoperative breast magnetic resonance imaging with diffusion-weighted imaging (DWI) were included in this study. Presence of rim enhancement on contrast-enhanced T1-weighted imaging and hyperintense rim on DWI were visually assessed. Pathologic data about presence of recurrence and presence of lymphovascular invasion (LVI) were reviewed. Statistics for relative risk of recurrence carried out. Results Of the 101, 13 cases (12.9%) were recurred after a median follow-up of 18.5 months. Rim enhancement was more frequently seen in the LVI-positive group (P = 0.046). Hyperintense rim on DWI and apparent diffusion coefficient values showed no significant relationship with clinical-pathologic factors. Conclusions Rim enhancement was significantly associated with positive LVI status in patients with triple-negative breast cancer. Our study suggests that rim enhancement may be useful to predict the prognosis.

    Original languageEnglish
    Pages (from-to)252-256
    Number of pages5
    JournalJournal of Computer Assisted Tomography
    Volume43
    Issue number2
    DOIs
    StatePublished - 1 Mar 2019

    Bibliographical note

    Publisher Copyright:
    © 2018 Wolters Kluwer Health, Inc. All rights reserved.

    Keywords

    • apparent diffusion coefficients
    • lymphovascular invasion
    • magnetic resonance imaging
    • rim enhancement
    • triple-negative breast cancer

    Fingerprint

    Dive into the research topics of 'Associations between Magnetic Resonance Imaging Findings and Clincopathologic Factors in Triple-Negative Breast Cancer'. Together they form a unique fingerprint.

    Cite this